Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumors. - Papadopoulos KP; Sharma MR; Dummer R; Colombo I; Ramelyte E; Seamon L; Rasco DW; Rodriguez-Freixinos V; Dozio V; Tat T; Luong N; Mathon C; et al. (European journal of cancer (Oxford, England : 1990), 2026)